Mohammed Ibrahim

ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer

Guru Sonpavde, Andrea Necchi, Shilpa Gupta et al. · Future Oncology · 2019 · 92 citations · Full text

Medicine, Oncology, Pharmacology +17

A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer

Mark Clemons, Dean Fergusson, Demetrios Simos et al. · Annals of Oncology · 2020 · 37 citations

Pharmacy, Oncology, Pharmacotherapy +15

The use of routine monitoring and evaluation systems to assess a referral model of family planning and HIV service integration in Nigeria

N. Chabikuli, D D Awi, Ogo Chukwujekwu et al. · AIDS · 2009 · 35 citations

Public Health, Community Health, Infectious Disease Control +17

Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy—a survey of health care providers and patients

Carmel Jacobs, Brian Hutton, Sasha Mazzarello et al. · Supportive Care in Cancer · 2015 · 16 citations

Medicine, Oncology, Pharmacology +12

Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study

Ricardo Fernandes, Sasha Mazzarello, Anil A. Joy et al. · Supportive Care in Cancer · 2018 · 15 citations

Medicine, Oncology, Chemotherapy +14